SIC
PRAX icon

SJS Investment Consulting’s Praxis Precision Medicines PRAX Stock Holding History

SJS Investment Consulting’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$670 Sell
2
-2
-50% -$633 ﹤0.01% 2167
2026
Q1 		$1.29K Buy
4
+3
+300% +$928 ﹤0.01% 1386
2025
Q4 		$295 Buy
+1
New +$186 ﹤0.01% 1690

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

SJS Investment Consulting's PRAX Position: Q2 2026 in Review

SJS Investment Consulting reduced its Praxis Precision Medicines (PRAX) stake by 50% in Q2 2026, selling an estimated $633 and leaving 2 shares worth $670. The position accounts for ﹤0.01% of the portfolio, ranked #2167.

SJS Investment Consulting first reported a position in PRAX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.29K in Q1 2026. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • SJS Investment Consulting held 2 shares of Praxis Precision Medicines worth $670 as of Q2 2026.
  • SJS Investment Consulting sold 2 Praxis Precision Medicines shares in Q2 2026, an estimated $633.
  • Praxis Precision Medicines made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2167 holding.
  • SJS Investment Consulting first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 3 quarters since.
  • SJS Investment Consulting's Praxis Precision Medicines position peaked at $1.29K in Q1 2026.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.